Avalon Trust’s CME Group CME Stock Holding History

Avalon Trust’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6	Closed	-$1.62K	–	469
2025 Q3	$1.62K	Buy	+6	New	+$1.63K	﹤0.01%	472

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Avalon Trust's CME Position: Q4 2025 in Review

Avalon Trust sold out of CME Group (CME) in Q4 2025, closing a stake of 6 shares — an estimated $1.62K sold.

Avalon Trust first reported a position in CME in Q3 2025 and held it in 1 quarter. The position peaked at $1.62K in Q3 2025. 1,736 funds tracked by Wall St. Rank hold CME as of Q4 2025.

Avalon Trust reported no remaining CME Group position as of Q4 2025 after selling out during the quarter.
Avalon Trust sold 6 CME Group shares in Q4 2025, an estimated $1.62K.
Avalon Trust first reported a position in CME Group in Q3 2025 and held it in 1 quarter.
Avalon Trust's CME Group position peaked at $1.62K in Q3 2025.
1,736 funds tracked by Wall St. Rank held CME Group as of Q4 2025.

Based on Avalon Trust's 13F filing for Q4 2025, filed 9 Feb 2026.